Loading...
DOCUMENTS
20
NOTICES
33
MOTS CLES
Colon cancer
Colorectal cancer
Methylation
Therapeutics
DNA methylation
Algorithm
Colonic epithelial primary cells
Contraindication
Original Article Clinical
Epigenetics
Immune cells
Disability
IL23
Dysbiose
Inclusion
Gene expression
Crohn’s disease
Anti-TNF
Neoadjuvant chemotherapy
Inflammatory bowel diseases
Eradication
COLON-CANCER
Clinical guidelines
Monitoring
Inhibitor
Survival
Epigénétiques
Anti-TNF agents
Cost effectiveness
Cell adhesion
Colon
Bactéries
RISK
Thérapie ciblée
18 FDG-PET/CT
MORTALITY
Ustekinumab
Disease Progression
PCR
Patients experience
Genes
Méthylation
Patient-reported outcome
Colectomy
Gènes
Screening
Primary sclerosing cholangitis
Biomarker
Dysbiosis
Fecal microbiota
IL12
Safety
Drug
Gene methylation
Parvimonas micra
Inflammatory Bowel Diseases
Colorectal cancer Colibactin and lipids
Stricture
Helicobacter pylori
HIV
Microbiota
Microbiote
Rituximab
Clinical trial
Surgery
Tuberculosis
MALT
Kidney diseases
Venous thromboembolism
Over 80s
Immunosuppressant
Inflammatory bowel disease
Heart disease risk factors
Small molecules
Consensus
Disease progression
Acceptability
Biologics
Cancer
Bacteria
Intestinal crypts
Crohn's disease
MARKER
Ulcerative colitis
MICROBIOTA
IBD
Resistance
Vedolizumab
Résistance
DNA METHYLATION
CARCINOGENESIS
Rituximab plus chlorambucil
Effectiveness
Eligibility
Endoscopic treatment
Maintenance therapy
Upper gastrointestinal tract
Alkylating agents
Tailored therapy
T1118 translocation
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩
-
Maria Nachury, Yoram Bouhnik, Mélanie Serrero, Jerome Filippi, Xavier Roblin, et al.. Patients’ real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group. Digestive and Liver Disease, 2021, 53 (4), pp.434-441. ⟨10.1016/j.dld.2020.10.020⟩. ⟨hal-03038260⟩
-
-
Julien Tap, Aurélien Amiot, Véronique Jarrousse, Sandra Guilmeau, Jeanne Tran Vannhieu, et al.. Early Phenotypical Changes Induced By Transfer Of Human Fecal Microbiota from Colorectal Cancer Patients To Germ-Free Mice. International Journal of Cancer and Oncology, 2017, 4 (1), pp. 1-11. ⟨10.15436/2377-0902.16.1128⟩. ⟨hal-03825702⟩
-
Nicolas Petitdidier, Laurent Beaugerie, Franck Carbonnel, Anne Bourrier, Xavier Treton, et al.. Real-world use of therapeutic drug monitoring of CT-P13 in patients with inflammatory bowel disease: A 12-month prospective observational cohort study. Clinics and Research in Hepatology and Gastroenterology, 2020, 44, pp.609 - 618. ⟨10.1016/j.clinre.2019.11.008⟩. ⟨hal-03492351⟩
-
-
Nicolas Petitdidier, Jenny Tannoury, Nicola De’angelis, Charlotte Gagniere, Anne Hulin, et al.. Patients’ perspectives after switching from infliximab to biosimilar CT-P13 in patients with inflammatory bowel disease: A 12-month prospective cohort study. Digestive and Liver Disease, 2019, 51, pp.1652 - 1660. ⟨10.1016/j.dld.2019.08.020⟩. ⟨hal-03489097⟩